Literature DB >> 10639597

Different expression of positive and negative regulators of hepatocyte growth in growing and shrinking hepatic lobes after portal vein branch ligation in rats.

T Uemura1, M Miyazaki, R Hirai, H Matsumoto, T Ota, R Ohashi, N Shimizu, T Tsuji, Y Inoue, M Namba.   

Abstract

Portal vein branch embolization is often performed before hepatectomy to prevent postoperative liver failure. It is, however, still not clear how the embolized lobe shrinks and the non-embolized lobe proliferates in counterbalance. We investigated the expression of positive and negative regulators of hepatocyte growth to clarify the mechanisms of liver growth and atrophy in a rat portal vein ligation (PVL) model compared with partial hepatectomy (PH). A significant increase in DNA synthesis within the non-ligated lobe reached a peak at 36 h, a delay of 12 h as compared with PH, while no increase occurred in the ligated lobe. Expression of hepatocyte growth factor mRNA remarkably increased in the non-ligated growing lobe between 6 and 24 h, but was only slightly elevated in the ligated shrinking lobe. Contrarily, negative regulators of hepatocyte proliferation, such as TGF-beta1 and IL-1beta, were strongly expressed in the ligated shrinking lobe. Thus, the changes of portal venous flow and/or pressure caused by PVL may contribute to induction of different kinds of growth factors between the ischemic and non-ischemic lobes; these factors possibly regulate liver regeneration and atrophy after PVL.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639597     DOI: 10.3892/ijmm.5.2.173

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  9 in total

Review 1.  Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review.

Authors:  Y Yokoyama; M Nagino; Y Nimura
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

2.  Impact of biomarkers expression before and after portal vein embolization on recurrence after two-stage hepatectomy for colorectal liver metastases.

Authors:  Masato Narita; Elie Oussoultzoglou; Marie-Pierre Chenard; Pascal Fuchshuber; Edoardo Rosso; Patrick Pessaux; Daniel Jaeck; Philippe Bachellier
Journal:  J Gastrointest Surg       Date:  2011-11-29       Impact factor: 3.452

3.  Inhibition of DNA synthesis in cultured hepatocytes by endotoxin-conditioned medium of activated stellate cells is transforming growth factor-beta and nitric oxide-independent.

Authors:  T Uemura; C R Gandhi
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

4.  Liver regeneration and the atrophy-hypertrophy complex.

Authors:  Robin D Kim; Jae Sung Kim; Go Watanabe; Dagmara Mohuczy; Kevin E Behrns
Journal:  Semin Intervent Radiol       Date:  2008-06       Impact factor: 1.513

5.  Portal vein ligation accelerates tumor growth in ligated, but not contralateral lobes.

Authors:  Nozomu Sakai; Callisia N Clarke; Rebecca Schuster; John Blanchard; Amit D Tevar; Michael J Edwards; Alex B Lentsch
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

6.  Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinoma.

Authors:  Wu Ji; Jie-Shou Li; Ling-Tang Li; Wu-Hong Liu; Kuan-Sheng Ma; Xiang-Tian Wang; Zhen-Ping He; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

7.  Expression of tumor necrosis factor-alpha converting enzyme in liver regeneration after partial hepatectomy.

Authors:  Xian-Ming Lin; Ying-Bin Liu; Fan Zhou; Yu-Lian Wu; Li Chen; He-Qing Fang
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

8.  Effect of portal vein embolisation on the growth rate of colorectal liver metastases.

Authors:  V Pamecha; A Levene; F Grillo; N Woodward; A Dhillon; B R Davidson
Journal:  Br J Cancer       Date:  2009-02-10       Impact factor: 7.640

Review 9.  Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma.

Authors:  Toru Beppu; Kensuke Yamamura; Hirohisa Okabe; Katsunori Imai; Hiromitsu Hayashi
Journal:  Ann Gastroenterol Surg       Date:  2020-12-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.